214 results
8-K
EX-10.1
WINT
Windtree Therapeutics Inc
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
, proceeding, inquiry or investigation before or by the Principal Market, any court, public board, other Governmental Entity, self-regulatory organization … , there is not pending or contemplated, any investigation by the SEC involving the Company, any of its Subsidiaries or any current or former director
8-K
EX-2.1
WINT
Windtree Therapeutics Inc
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
performing a reasonable investigation (including due inquiry with Seller’s patent counsel with respect to the representations and warranties set forth … , audit, hearing, investigation, inquiry, litigation or suit (whether civil, criminal, administrative, judicial or investigative, whether formal or informal
8-K
EX-4.1
vqk4g gjxsv46n
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-3.1
2vblsvq
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-10.2
fhpe61vi
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-10.2
etgzyncxsmxghc 8q1xe
25 Jan 24
Entry into a Material Definitive Agreement
8:34am
8-K
EX-10.1
wlt 1wfi684
25 Jan 24
Entry into a Material Definitive Agreement
8:34am
8-K
EX-1.1
9qx4 vuo63
9 Nov 23
Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates
4:21pm
8-K
EX-4.1
j8opmhbc 4hryuz8cil
24 Apr 23
Entry into a Material Definitive Agreement
4:40pm
8-K
EX-1.1
3fhpff v482kdt
24 Apr 23
Entry into a Material Definitive Agreement
4:40pm